Closed-loop drug infusion for control of heart-rate trajectory in pharmacological stress tests

C P Valcke1, H J Chizeck

  • 1Gensia, Inc., San Diego, CA 92121, USA. valcke@gensia.com

Insights

A new system using arbutamine automates pharmacological stress testing for coronary artery disease (CAD) diagnosis. This closed-loop algorithm effectively controls heart rate, offering a safer and more efficient diagnostic method for cardiologists.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biomedical Engineering

Background:

  • Coronary artery disease (CAD) diagnosis is crucial in cardiology.
  • Pharmacological stress testing is an emerging alternative to exercise stress testing (ETT).
  • A novel device-drug system for CAD diagnosis has been developed.

Purpose of the Study:

  • To develop and evaluate a closed-loop control algorithm for arbutamine infusion.
  • To create a pharmacodynamic (PD) model of heart rate (HR) response to arbutamine.
  • To assess the safety and efficacy of automated arbutamine delivery for stress testing.

Main Methods:

  • Development of a closed-loop control algorithm for intravenous arbutamine delivery.
  • Creation of a PD model to predict HR response to arbutamine.
  • Estimation of model parameters using clinical data from volunteers and patients.
  • Testing the algorithm via simulations, animal studies, and human clinical trials.

Main Results:

  • The control algorithm successfully managed HR increase along a predetermined trajectory.
  • Clinical trials demonstrated the algorithm's effectiveness in controlling arbutamine infusion.
  • Simulations, animal, and human trials validated the algorithm's performance.

Conclusions:

  • The developed algorithm enables precise control of arbutamine infusion for stress testing.
  • Automated drug delivery offers an efficient, effective, and safe method for pharmacological stress tests.
  • This system enhances the diagnostic capabilities for cardiologists managing CAD patients.

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...